Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
597 |
|
| Actual shortage: | 85 (14%) | |
| Anticipated shortage: | 2 (0%) | |
| Avoided shortage: | 16 (3%) | |
| Resolved: | 494 (83%) | |
Discontinuation Reports |
69 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (74%) | |
| Reversed: | 11 (16%) | |
Late reports |
53 (8%) |
|
Overdue reports |
49 (52%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BETAHISTINE | 24MG | TABLET | Resolved | 2019-03-29 | 2019-07-26 | 79889 |
| BETAHISTINE | 24MG | TABLET | Actual shortage | 2024-12-04 | 2024-12-04 | 244732 |
| BETAHISTINE | 16MG | TABLET | Actual shortage | 2024-11-12 | 2024-11-12 | 242791 |
| BICALUTAMIDE | 50MG | TABLET | Actual shortage | 2024-03-26 | 2024-07-02 | 223349 |
| BISOPROLOL | 5MG | TABLET | Resolved | 2020-03-26 | 2020-03-27 | 109422 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-22 | 2020-02-07 | 99541 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-02-19 | 2020-03-24 | 106721 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-03-26 | 2020-04-08 | 109432 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-12 | 2024-03-02 | 144047 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-12 | 2024-03-02 | 144044 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2017-04-10 | 2017-05-10 | 6263 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2023-07-17 | 2023-09-05 | 198795 |
| CANDESARTAN | 8MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114758 |
| CANDESARTAN | 32MG | TABLET | Resolved | 2020-03-26 | 2020-04-01 | 109439 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2023-11-22 | 2023-12-26 | 211086 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2019-01-25 | 2019-05-16 | 73514 |
| CANDESARTAN | 8MG | TABLET | Resolved | 2020-02-27 | 2020-05-12 | 107299 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2019-04-09 | 2019-05-16 | 80863 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2023-07-18 | 2023-11-06 | 198936 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2019-01-25 | 2019-02-26 | 73517 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107342 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
| DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2412 |
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
| FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
| FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
| FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
| HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |